Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apolipoprotein A-IV/ApoA4 Mouse anti-Human, Clone: APOA4/3372, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$268.00

Specifications

Antigen Apolipoprotein A-IV/ApoA4
Clone APOA4/3372
Concentration 0.2 mg/ml
Dilution Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Applications Immunohistochemistry (Paraffin), Peptide Array
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB121880
SDP
View Documents
Novus Biologicals
NBP30720320UG
20 μg
Each of 1 for $268.00
Only null left
Add to Cart
 
Description

Description

Apolipoprotein A-IV/ApoA4 Monoclonal specifically detects Apolipoprotein A-IV/ApoA4 in Human samples. It is validated for Immunohistochemistry-Paraffin, Protein Array.
Specifications

Specifications

Apolipoprotein A-IV/ApoA4
0.2 mg/ml
Immunohistochemistry (Paraffin), Peptide Array
Unconjugated
Mouse
Lipid and Metabolism
10 mM PBS with 0.05% BSA
337
IgG2b κ
Protein A or G purified
APOA4/3372
Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Monoclonal
Purified
RUO
Human
apo-AIV, ApoA-IV, Apolipoprotein A4, apolipoprotein A-IV, MGC142154, MGC142156
Human recombinant Apolipoprotein A-IV/ApoA4 protein fragment (around aa 239-371) (exact sequence is proprietary)
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.